Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
Conditions: Pneumococcal Immunisation; Diphtheria Immunisation; Tetanus Immunisation; Pertussis Immunisation; Hepatitis B Immunisation; Haemophilus Influenzae Type b Immunisation; Polio Immunisation; Measles Immunisation; Rubella Immunisation; Varicella Immunisation; Mumps Immunisation Interventions: Biological: SP0202-IIb Pneumococcal Conjugate Vaccine formulation 1; Biological: SP0202-VI Pneumococcal Conjugate Vaccine formulation 2; Biological: SP0202-VII Pneumococcal Conjugate Vaccine formulation 3; Biological: Varicella Virus Vaccine Live; Biological: Measles, Mumps, and Rubella Virus Vaccine Live; Biological: Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]; Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate); Biological: Rotavirus Vac cine, Live, Oral, Pentavalent; Biological: Hepatitis B Vaccine [Recombinant] Sponsor: Sanofi Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: ActHIB | Diphtheria | Measles | Measles Vaccine | Meningitis Vaccine | Mumps | Mumps Vaccine | Pediatrics | Pneomococcal Vaccine | Research | Rotavirus | Rotavirus Vaccine | Rubella | Rubella Vaccine | Study | Tetanus | Tetanus Diptheria Pertussis Vaccine Tdap,Dtap,Dpt | Tetanus Vaccine | Vaccines | Whooping Cough (Pertussis) Vaccine